Global X Genomics & Biotechnology ETF
GNOM
GNOM
59 hedge funds and large institutions have $31M invested in Global X Genomics & Biotechnology ETF in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
33% less call options, than puts
Call options by funds: $2K | Put options by funds: $3K
Holders
59
Holding in Top 10
–
Calls
$2K
Puts
$3K
Top Buyers
| 1 | +$624K | |
| 2 | +$576K | |
| 3 | +$349K | |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$323K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$278K |
Top Sellers
| 1 | -$6.2M | |
| 2 | -$544K | |
| 3 | -$219K | |
| 4 |
JJBC
James J. Burns & Company
Melville,
New York
|
-$214K |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$147K |